These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14725027)

  • 1. [Beta blocker in heart failure. Dosage too low].
    Traut
    MMW Fortschr Med; 2003 Nov; 145(47):14. PubMed ID: 14725027
    [No Abstract]   [Full Text] [Related]  

  • 2. A COMET lost.
    Goldstein S
    Ital Heart J; 2003 Oct; 4(10):653-4. PubMed ID: 14664277
    [No Abstract]   [Full Text] [Related]  

  • 3. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 5. Dramatic new trial results settle controversy in chronic heart failure.
    Cardiovasc J S Afr; 2003; 14(3):157. PubMed ID: 12931733
    [No Abstract]   [Full Text] [Related]  

  • 6. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 7. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial.
    Metra M; Torp-Pedersen C; Swedberg K; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Lutiger B; Scherhag A; Lukas MA; Charlesworth A; Poole-Wilson PA
    Eur Heart J; 2005 Nov; 26(21):2259-68. PubMed ID: 16040619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The COMET trial.
    Bristow MR; Adams KF; Bauman JL; Feldman AM; Giles TD; Goldstein S; Mann DL; Talbert RL
    Congest Heart Fail; 2005; 11(1):39-47. PubMed ID: 15722669
    [No Abstract]   [Full Text] [Related]  

  • 10. Individualising heart failure patients to beta-blocker therapy.
    Cardiovasc J S Afr; 2004; 15(2):88, 91. PubMed ID: 15148544
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 12. Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET.
    Metra M; Torp-Pedersen C; Cleland JG; Di Lenarda A; Komajda M; Remme WJ; Dei Cas L; Spark P; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2007 Sep; 9(9):901-9. PubMed ID: 17581778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comment on COMET: how to interpret a positive trial?
    Massie BM
    J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

  • 15. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in Japan and the United States.
    Alexander JH
    Am Heart J; 2004 Feb; 147(2):200-1. PubMed ID: 14760313
    [No Abstract]   [Full Text] [Related]  

  • 17. Carvedilol versus controlled-release metoprolol for elderly veterans with heart failure.
    Rector TS; Anand IS; Nelson DB; Ensrud KE
    J Am Geriatr Soc; 2008 Jun; 56(6):1021-7. PubMed ID: 18384583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of beta-blockers in heart failure].
    Inoko M; Nohara R
    Nihon Rinsho; 2003 May; 61(5):816-20. PubMed ID: 12755008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure: Carvedilol or Metoprolol Evaluation Study.
    Fröhlich H; Zhao J; Täger T; Cebola R; Schellberg D; Katus HA; Grundtvig M; Hole T; Atar D; Agewall S; Frankenstein L
    Circ Heart Fail; 2015 Sep; 8(5):887-96. PubMed ID: 26175538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.
    Bauman JL; Talbert RL
    J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):117-28. PubMed ID: 15309248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.